Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress.
Timed with the formal end of the COVID-19 public health emergency on May 11, an NACDS ad is punctuating the occasion with a “thank you” to pharmacists and pharmacy teams.
Between 2019 and 2022, the number of prescriptions dispensed annually through IOPs increased from 64 million to 85 million at a compounded annual growth rate of 10%.
Spending on medicines—at net manufacturer prices—reached $429 billion in 2022, growing 5.3% including the continued contribution of COVID-19 vaccines and therapeutics, the report revealed.
